Altimmune is a late clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is developing pemvidutide, a GLP-1/glucagon dual ...

Obesity and pharmacology experts are warning about hidden safety risks and efficacy issues for many types of medications in ...

In a report released yesterday, Joanne Wuensch from Citi reiterated a Buy rating on Dexcom (DXCM – Research Report), with a price target of ...

Meriaura Group Plc's annual report including the annual accounts, the report of the Board of Directors and the auditor's report for the year 2024 has been published.